MARIBEL KAMP: Open Payments
NPI 1790385037 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,248 in 92 payments from 19 companies in 2025. Trend: 2023 $1,651 · 2024 $2,092 · 2025 $2,248
Food & beverage: $2,248
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $324 |
| OPKO Pharmaceuticals, LLC | 20 | $254 |
| AstraZeneca Pharmaceuticals LP | 6 | $206 |
| AKEBIA THERAPEUTICS INC | 7 | $180 |
| Travere Therapeutics, Inc. | 4 | $179 |
| Otsuka America Pharmaceutical, Inc. | 3 | $160 |
| Calliditas Therapeutics US Inc. | 6 | $158 |
| Ardelyx, Inc. | 9 | $155 |
| Corcept Therapeutics | 1 | $125 |
| Novo Nordisk Inc | 5 | $104 |
Products named: RAYALDEE, Vafseo, KRYSTEXXA, TARPEYO, IBSRELA, Filspari, Korlym, LOKELMA.
Industry payments across TX — which companies pay providers there.
